Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Joon Seong | - |
dc.contributor.author | Lee, Sung-Eun | - |
dc.contributor.author | Jeong, Seong Hyun | - |
dc.contributor.author | Jang, Eun-Jung | - |
dc.contributor.author | Choi, Mi-Yeon | - |
dc.contributor.author | Kim, Hyeoung-Joon | - |
dc.contributor.author | Kim, Yeo-Kyeoung | - |
dc.contributor.author | Kim, Sung-Hyun | - |
dc.contributor.author | Zang, Dae Young | - |
dc.contributor.author | Oh, Sukjoong | - |
dc.contributor.author | Koo, Dong Hoe | - |
dc.contributor.author | Kim, Hawk | - |
dc.contributor.author | Do, Young Rok | - |
dc.contributor.author | Kwak, Jae-Yong | - |
dc.contributor.author | Kim, Jeong-A | - |
dc.contributor.author | Kim, Dae-Young | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Lee, Won Sik | - |
dc.contributor.author | Chang, Myung Hee | - |
dc.contributor.author | Park, Jinny | - |
dc.contributor.author | Kwon, Ji Hyun | - |
dc.contributor.author | Kim, Dong-Wook | - |
dc.date.available | 2020-02-28T02:45:24Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-02-01 | - |
dc.identifier.issn | 1042-8194 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8574 | - |
dc.description.abstract | The aim of this study was to investigate the changes in health-related profiles including quality-of-life (HRQoL) in the chronic myeloid leukemia (CML) patients who discontinued imatinib (IM). An HRQoL survey composed of 43 parameters about IM-related adverse events (AEs), physical health-related and mental health-related was provided at baseline and 6 months post-discontinuation. A total of 55 patients with a sustained UMRD over 6 months were analyzed. Although the majority of IM-related AEs were significantly improved, unexpectedly pruritus and musculoskeletal pain worsen or newly develop in 29.1% and 21.8% of patients, respectively. The improvements in physical and mental health condition were variable in individual patients. In addition, rapid restorations of the hematological and biochemical parameters were observed. The results showed the changes of HRQoL and laboratory tests in treatment-off patients and the necessity of continuing physical and mental support for some patients in tyrosine kinase inhibitor (TKI)-off studies. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.relation.isPartOf | LEUKEMIA & LYMPHOMA | - |
dc.subject | QUALITY-OF-LIFE | - |
dc.subject | CHRONIC MYELOGENOUS LEUKEMIA | - |
dc.subject | MOLECULAR RESPONSE | - |
dc.subject | MESYLATE | - |
dc.subject | DISCONTINUATION | - |
dc.subject | THERAPY | - |
dc.subject | OUTCOMES | - |
dc.subject | QUESTIONNAIRE | - |
dc.subject | GLUCOSE | - |
dc.subject | CELLS | - |
dc.title | Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000368511800017 | - |
dc.identifier.doi | 10.3109/10428194.2015.1049166 | - |
dc.identifier.bibliographicCitation | LEUKEMIA & LYMPHOMA, v.57, no.2, pp.341 - 347 | - |
dc.identifier.scopusid | 2-s2.0-84954466698 | - |
dc.citation.endPage | 347 | - |
dc.citation.startPage | 341 | - |
dc.citation.title | LEUKEMIA & LYMPHOMA | - |
dc.citation.volume | 57 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Park, Jinny | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Chronic myeloid leukemia | - |
dc.subject.keywordAuthor | imatinib cessation | - |
dc.subject.keywordAuthor | quality-of-life | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | CHRONIC MYELOGENOUS LEUKEMIA | - |
dc.subject.keywordPlus | MOLECULAR RESPONSE | - |
dc.subject.keywordPlus | MESYLATE | - |
dc.subject.keywordPlus | DISCONTINUATION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | QUESTIONNAIRE | - |
dc.subject.keywordPlus | GLUCOSE | - |
dc.subject.keywordPlus | CELLS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.